Atropos Therapeutics Revenue

Biotechnology Research • San Carlos, California, United States • 1-10 Employees

Atropos Therapeutics revenue & valuation

Annual revenue	$15,000,000
Revenue per employee	$5,000,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$48,000,000
Total funding	No funding

Key Contact at Atropos Therapeutics

Pauline Jen Ryan

Chief Executive Officer

Company overview

Headquarters	San Carlos, California, United States
Website	atroposthera.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Medicine, Cancer, Aging, Senescence
Founded	2018
Employees	1-10
Socials

Atropos Therapeutics Email Formats

Atropos Therapeutics uses 1 email format. The most common is {first initial} (e.g., j@atroposthera.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@atroposthera.com	100%

About Atropos Therapeutics

Atropos Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs against aging disorders and cancer using its proprietary senescence technology. Our pipeline is preclinical stage and is NIH-funded. We are a relatively new company and welcome investors and colleagues to join our mission.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Atropos Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Atropos Therapeutics has never raised funding before.

Frequently asked questions

Atropos Therapeutics is located in San Carlos, California, US.

Atropos Therapeutics generates an estimated annual revenue of $15,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Atropos Therapeutics has an estimated valuation of $48,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Atropos Therapeutics was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

Atropos Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Atropos Therapeutics

Pauline Jen Ryan

Chief Executive Officer

4.8

40,000 users